Board of Directors approved the 2022Q2 consolidated financial statements.
· Issued by Taiwan Hopax Chemicals Manufacturing Co. Ltd.
Close
Today's Information
Provided by: TAIWAN HOPAX CHEMS.MFG.CO.,LTD.
SEQ_NO
1
Date of announcement
2022/08/09
Time of announcement
16:24:05
Subject
Board of Directors approved the 2022Q2
consolidated financial statements.
Date of events
2022/08/09
To which item it meets
paragraph 31
Statement
1.Date of the board of directors submitted or approved:2022/08/09
2.Date of the audit committee approved:2022/08/09
3.Start and end dates of financial reports or unaudited financial
information of the reporting period(XXXX/XX/XX~XXXX/XX/XX):
2022/01/01~2022/06/30
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):2,805,358
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):722,259
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):338,378
7.Profit (loss) before tax accumulated from 1/1 to end of the period
(thousand NTD):355,398
8.Profit (loss) accumulated from 1/1 to end of the period
(thousand NTD):272,433
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):272,433
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):1.57
11.Total assets end of the period (thousand NTD):6,796,259
12.Total liabilities end of the period
(thousand NTD):3,561,336
13.Equity attributable to owners of parent end of the
period (thousand NTD):3,234,923
14.Any other matters that need to be specified:None.
